Selection of the optimal dose for an ultra-short course subcutaneous immunotherapy (SCIT) for Rhinoconjunctivitis for Birch Allergic patients

被引：0

作者：

Worm, Margitta ^{[1
]}

Zielen, Stefan ^{[2
]}

Higenbottam, Tim ^{[3
]}

Pfaar, Oliver ^{[4
]}

Mosges, Ralph ^{[5
]}

Aberer, Werner ^{[6
]}

Kramer, Matthias ^{[7
]}

Skinner, Murray ^{[3
]}

Lees, Bev ^{[3
]}

机构：

[1] Charite Univ Med Berlin, Berlin, Germany

[2] Goethe Univ Frankfurt Main, Klinikum Frankfurt 2Univ, Frankfurt, Germany

[3] Allergy Therapeut, Worthing, England

[4] Univ Med Mannheim, Dept Otorhinolaryngol Head & Neck Surg, Mannheim, Germany

[5] Univ Cologne, Cologne, Germany

[6] Med Univ Graz, Dept Dermatol & Venerol, Graz, Austria

[7] Bencard GmbH, Munich, Germany

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 139卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2016.12.491

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

478

引用

页码：AB150 / AB150

页数：1

共 50 条

[1] Selection of the optimal dose for an ultra-short course subcutaneous immunotherapy for rhinoconjunctivitis for birch allergic patients. EUDRACT number 2015-000984-15
Worm, M.
Zielen, S.
Higenbottam, T.
Pfaar, O.
Mosges, R.
Aberer, W.
Lee, D.
Kramer, M. F.
Skinner, M. A.
ALLERGY, 2017, 72 : 201 - 202
[2] Immunologic effect and safety of ultra-short course subcutaneous immunotherapy (μSCIT) with polmnex quattro ragweed
Howland, W.
Kaiser, H.
Cypear, D.
Rowe, M.
Amersdorffer, J.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A13 - A13
[3] Ultra-short course immunotherapy (uSCIT) with pollinex quattro in patients with allergic asthma
von Weikersthal-Drachenberg, K. Fischer
Zielen, S.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A88 - A88
[4] EFFECT OF ULTRA SHORT COURSE SUBCUTANEOUS IMMUNOTHERAPY ON SPECIFIC IGG AND IGE LEVELS COMPARED WITH PLACEBO IN PATIENTS WITH RAGWEED POLLEN-ALLERGIC RHINOCONJUNCTIVITIS
Howland, W. C.
Hamilton, R. G.
Holdich, T.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A23 - A23
[5] Significant benefits of combined symptom and medication scores for ultra short course subcutaneous immunotherapy compared with placebo in patients with grass pollen allergic rhinoconjunctivitis
Frew, A.
DuBuske, L.
Amersdorffer, J.
Holdich, T.
ALLERGY, 2009, 64 : 227 - 228
[6] Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen
Patel, Piyush
Holdich, Tom
von Weikersthal-Drachenberg, Karl J. Fischer
Huber, Birgit
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (01) : 121 - +
[7] Quality of life benefits for patients with seasonal grass pollen-allergic rhinoconjunctivitis receiving ultra short course subcutaneous immunotherapy (uSCIT) with MPL adjuvant
Keith, P.
Amersdorffer, J.
ALLERGY, 2009, 64 : 348 - 348
[8] Selection of patients for sublingual immunotherapy (SLIT) versus subcutaneous immunotherapy (SCIT)
Tabatabaian, Farnaz
Casale, Thomas B.
ALLERGY AND ASTHMA PROCEEDINGS, 2015, 36 (02) : 100 - 104
[9] Ultra-short preseasonal immunotherapy of depiquick grass pollen extract compared to placebo in patients with type-I allergic rhinoconjunctivitis
Ludger, K.
Matthias, B.
Sager, A.
Pfaar, O.
ALLERGY, 2010, 65 : 261 - 262
[10] The analysis of curative effect of allergic rhinitis patients with subcutaneous immunotherapy (SCIT)
Meng, C.
Sha, J.
Fu, Y.
Xiu, Q.
ALLERGY, 2016, 71 : 455 - 455

← 1 2 3 4 5 →